tbuckley/cabot-search huggingface dataset:
HISTORIC SALT-FREE DIET IN ASCITES.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Unicorn
Authors: Wallace C. Ellerbroek
Journal: JAMA (1968)

The unicorn was a fabulous beast who inhabited only the realm of mankind's imagination. But the student of human thinking will find it well worth his while to pursue such trails as the unicorn offers—not hoof marks in the forest, but black print on white or yellowed pages: the lair of<i>this</i>beast is in the library stacks, and not in the fields or on the wooded hills. The origins of the unicorn story are found back in the beginnings of recorded history. The Talmud in three places refers to a great ox with one horn that was the leader of Adam's herd, which was Adam's first sacrifice to his God. It also reports that the unicorn was too large to take in the Ark, and thus was forced to swim along behind—but when fatigued, was allowed to briefly rest the tip of its horn on the stern. The only
Pseudocholedochus Cyst
Authors: J. P. Partridge
Journal: BMJ (1960)

Pseudocholedochus CystCholedochus cyst has been well described on many occasions, and Alonso-Lej et al. (1959) have gathered 419 cases from the world literature, analysing 92 of them.There is, however, no published account of pseudocholedochus cyst, though it is likely, in view of the variety of causes ascribed to choledochus cyst, that some of the cases reported may have been of this nature.It is necessary to make the distinction in view of the difference in treatment. CASE REPORTA baby, born on December 3, 1957, was admitted to hospital when 3 months old on account of refusal to take her feeds for the previous three weeks.The mother had noticed that the stools had been pale and offensive.Examination at this time showed no abnormal physical
Abstract 19166: Transportation Time Does Not Affect Mortality in Patients With Type A Aortic Dissection in a Hospital Without Cardiothoracic Surgery
Authors: Hitoshi Susawa, Shinsuke Mikami, Hajime Takemoto, Yuki Nakao, Kengo Kobayashi, Haruki Tanaka, Kouichi Tanaka, Yasuki Kihara
Journal: Circulation (2015)

Introduction: Acute aortic dissection (AD) is a rare case, but if it occurs rapid diagnosis and treatment are needed. It is currently crucial for AD patients to be transferred to a specialized hospital in a safe and timely manner. However, transportation time does not fully access to affect mortality in these patients. Methods: We evaluated fifty-one subjects who were suspected aortic dissection between 2010 and 2014 in a hospital without cardiothoracic surgery. Thirty cases of AD confirmed with 64-slice computed tomography (20 cases of Stanford type A and 10 cases of type B) were divided into a high-risk group (eight cases, 8 Stanford type A and zero type B) and a low-risk group (22 cases, 12 Stanford type A and 10 type B) according to the hypotension (systolic blood pressure&lt;90 mmHg). The transportation time and mortality were compared between the high-risk group and the low-risk group, and the correlation between the measured transportation time and mortality was analyzed. Results: The transportation time and mortality were compared between Stanford type A and type B, and statistically significant differences were found. The transportation time and mortality were compared between the high-risk group and low-risk group, revealing a statistically significant difference (p &lt; 0.05). Moreover, a significant correlation was not found between the transportation time and mortality (r = 0.287; p = 0.367). CONCLUSIONS: The hypotensive patients are the greater transportation risk for AD patients with type A dissection. Transportation time does not affect mortality in patients with low-risk type A aortic dissection.
Fish Health and Environmental Health
Authors: Robert A. Murchelano
Journal: Environmental Health Perspectives (1990)

Surveys conducted to evaluate the health of marine-bottom fishes have been conducted in the eastern and western North Atlantic for the past 15 years, usually in conjunction with fish stock assessment cruises. The health of the fish sampled was evaluated using certain integumental and skeletal lesions and anomalies as markers to signify compromised health status. The results of these surveys indicate that fish health is poorer in coastal waters that have been anthropogenically degraded. Monitoring programs to determine the status and trends in levels of inorganic and organic contaminants in fish tissue and sediments have disclosed high levels of chemical contaminants in several coastal areas of the northeastern United States. Histopathological examinations of liver tissues of winter flounder, Pseudopleuronectes americanus, from Boston Harbor, one of the more chemically contaminated sites, has revealed a high prevalence of hepatocarcinoma.
Epidemiology of Hepatic Angiosarcoma in the United States: 1964-1974
Authors: Henry Falk, John Herbert, Steven Crowley, Kamal G. Ishak, Louis B. Thomas, Hans Popper, Glyn G. Caldwell
Journal: Environmental Health Perspectives (1981)

A nationwide survey of hepatic angiosarcoma (HAS) in the United States during the years 1964 through 1974 identified 168 cases. Of these, 42 cases (25%) were associated with known etiologic factors, such as vinyl chloride monomer exposure during preparation of poly(vinyl chloride), use of Thorotrast in angiography, exposure to inorganic arsenic, and treatment with androgenic-anabolic steroids; 126 cases (75%) are of uncertain etiology. HAS most often affects males (ratio of approximately 3:1), peaks in the sixth and seventh decades of life (somewhat earlier than other sarcomas of the liver) and appears to occur more often in the industrialized Northeast and Midwest (although reporting artifact may be a factor). There is an extraordinary relative risk for poly(vinyl chloride) polymerization workers; there may also be other chemical-industrial associations that require further investigation. Prospective epidemiologic studies of HAS should be considered as a means of identifying other causative factors (e.g., chemicals or drugs) related to HAS.
Coronary Care and the Community.
Authors: Desmond G. Julian
Journal: Annals of Internal Medicine (1968)

s1 May 1968Coronary Care and the Community.Desmond G. Julian, M.R.C.P.Desmond G. Julian, M.R.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-68-5-1157_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe coronary care unit of the Royal Infirmary, Edinburgh, appears, like its counterparts elsewhere, to have effected a substantial lowering of mortality in patients with acute myocardial infarction. However, a study of acute coronary incidents in the community suggests that the advent of the Coronary Care Unit has had little impact on total coronary mortality. This comparative ineffectiveness can be attributed to the occurrence of suddent death outside hospital, to insufficiently rapid admission to the Coronary Care Unit, and to a shortage of Coronary Care Unit beds, necessitating the care of many patients in general medical wards. Improvements in mortality... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Edinburgh, PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1968Volume 68, Issue 5Page: 1157-1157KeywordsAcute myocardial infarctionCardiac care unitMortalityPatients Issue Published: 1 May 1968 PDF downloadLoading ...
Las artritis gonocóccicas agudas: Su diagnóstico y tratamiento médico
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction
Journal: Annals of the Rheumatic Diseases (2013)

Figure 2 of this paper was mistakenly published with identical parts A and B. The correct figure is below.In addition, as there are no separate parts '(A)' and '(B)' in figure 3, the labels '(A)' and '(B)' should not have been present in figure 3 legend.The corrected legend for figure 3 is:
Authors' reply
Authors: B L Hazleman, G Pountain
Journal: BMJ (1995)

<h3>Abstract</h3> Patients with hematologic malignancies have poor outcomes from COVID infection and are less likely to mount an antibody response after COVID infection. There is limited data on the efficacy of the COVID vaccines in lymphoma patients, and to suggest the optimal timing of vaccination to elicit immunity in patients receiving immunochemotherapy. This is a retrospective study of adult lymphoma patients who received the COVID vaccine between 12/1/2020 and 11/30/2021. The primary endpoint was a positive anti-COVID spike protein antibody titer following the primary COVID vaccination series. The primary series was defined as 2 doses of the COVID mRNA vaccines or 1 dose of the COVID adenovirus vaccine. Subgroups were compared using Fisher’s exact test, and unadjusted and adjusted logistic regression models were used for univariate (UVA) and multivariate (MVA) analyses. A total of 243 patients were included in this study; 72 patients (30%) with indolent lymphomas; 56 patients (23%) with Burkitt’s, diffuse large B-cell lymphoma (DLBCL), and primary mediastinal B-cell lymphoma (PMBL) combined; 55 patients (22%) with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL); and 44 patients (18%) with Hodgkin and T-cell lymphomas (HL/TCL) combined. One-hundred fifty-eight patients (65%) developed anti-COVID spike protein antibodies after completing the primary COVID vaccination series. Thirty-eight of 46 (83%) patients who received an additional primary shot and had resultant levels produced anti-COVID spike protein antibodies. When compared to other lymphoma types, patients with CLL/SLL had a numerically lower seroconversion rate of 51% following the primary series whereas patients with HL/TCL appeared to have a robust antibody response with a seropositivity rate of 77% (p=0.04). Lymphoma patients are capable of mounting a humoral response to the COVID mRNA vaccines. Further studies are required to confirm our findings, including whether T-cell immunity would be of clinical relevance in this patient population.
GOVERNMENT REPORTS ON MEDICAL EDUCATION
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Genome Chief Steps Down
Journal: JAMA (2008)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SOCIETY NEWS.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vaccine disputes
Authors: R. Coombes
Journal: BMJ (2009)

Thank you for your interest in spreading the word about The BMJ.NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Username * Your Email * Send To * You are going to email the following Vaccine disputes Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Address of a Sanitarium in Adirondacks.
Authors: None N. H. P.
Journal: JAMA (1894)

lishes this fortuitous combination of items: "The American Academy of Medicine will meet in Jeffer- son, N. Y., August 29 and 30." "[unk].In debility from seminal losses, elixir nutrans, [unk]viij.Sig.Dessertspoonful four times a day, after
OBITUARY
Authors: WILLIAM HEWSON MOOK
Journal: British Journal of Dermatology (1934)

Journal Article OBITUARY Get access WILLIAM HEWSON MOOK WILLIAM HEWSON MOOK Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology and Syphilis, Volume 46, Issue 12, 1 December 1934, Page 537, https://doi.org/10.1111/j.1365-2133.1934.tb09771.x Published: 01 December 1934
Laetrilomania — Again
Authors: Arnold S. Relman
Journal: New England Journal of Medicine (1978)

However much we may wish it to, Laetrile is not about to disappear. Last May the Journal's editor expressed the exasperations of most physicians when he declared in these columns, "This Laetrile business is reaching the point of absurdity."1 Yet since that time 14 states have voted to legalize the drug, and a Federal District Court Judge has ruled that patients with terminal cancer may import Laetrile for their own use, provided they obtain a statement from their physician.All this activity is in the face of continued strong opposition from virtually every reputable cancer specialist and major medical organization . . .
Multi-institution quality improvement in supportive oncology: Results of the Coleman Supportive Oncology Collaborative (CSOC).
Authors: Julia Rachel Trosman, Betty Roggenkamp, Paramjeet Khosla, Teresa Lillis, Joanna Martin, Mary Pasquinelli, Eileen Knightly, Shelly S. Lo, Anne Bowman, Selina Lai-ming Chow, Urjeet Patel, Rosa Berardi, Aidnag Diaz, Sheetal Mehta Kircher, Christine B. Weldon
Journal: Journal of Clinical Oncology (2019)

33 Background: The Institute of Medicine and Commission on Cancer recommend systematic delivery of supportive oncology care for cancer patients. The CSOC is focused on quality improvement (QI) of supportive care across Chicago cancer centers (Weldon ASCO ’17). Supportive oncology includes distress, practical, family, physical, nutrition, pain, fatigue and care concerns. To support QI, cross-institution teams developed unique, relevant tools, methods, care delivery processes, patient handouts and online training. Methods: Ten centers (5 academic, 1 VA, 1 public, 2 safety net, 1 community) implemented supportive oncology screening and care delivery quality improvements. Centers collected data for relevant Quality Oncology Practice Initiative (QOPI) metrics. Analyses used simple frequencies and Fishers exact test. Results: Five of six QOPI measures were improved at statistically significant levels from 2014 to 2017, p &lt; .00001. Improvements are more modest in 2016 &amp; 2017 as 4 of the centers started this QI in 2017. Conclusions: The CSOC achieved significant improvements in supportive oncology screening and identifying and addressing patients’ needs and concerns. Additional work is needed to improve these measures to achieve the best quality of cancer care possible for every patient based on their needs and concerns. [Table: see text]
JAMA 75 YEARS AGO
Journal: JAMA (1975)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Consensus conference. The management of clinically localized prostate cancer
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Benchmarking the physician workforce
Authors: M. H. Floch
Journal: JAMA (1997)

<h3>In Reply.</h3> —Dr Tripp and colleagues highlight some important aspects raised by our article summarizing the outcome of the ICSI procedure. There have been 2 major concerns related to ICSI. One concern is the invasive nature of the procedure, but this approach now seems entirely compatible with normal development. Based on our results, it is clear that the manipulative technique of ICSI per se can no longer be regarded as an experimental procedure.<sup>1</sup>A second concern has been the necessary selection of spermatozoa from men with incomplete development of the excurrent duct system related to cystic fibrosis or of immature male germ cells in which ICSI is applied to the treatment of severely oligozoospermic or azoospermic men. This is not the first time that concerns have been raised about the use of suboptimal semen in assisted fertilization. However, among the conditions mentioned by Tripp et al, the incidence of hypospadias after